The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Global Hiv Vaccine Enterprise

  • Contact Person: Randy Goetz
  • Contact Phone: 212-461-3692
  • Contact Email: rgoetz@vaccineenterprise.org
  • Business Structure:
  • Corporate Entity (Tax Exempt)
  • Business Type:
  • Non-Profit Organization
  • Industries Served: Pharmaceutical Preparation Manufacturing, All Other Miscellaneous Chemical Product and Preparation Manufacturing, Other Commercial and Service Industry Machinery Manufacturing, Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
  • Product Areas: R&D-PROD/SERV IMPROVEMENT-A RES/EXP, R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (ADVANCED DEVELOPMENT), R&D-PROD/SERV IMPROVEMENT-ADV DEV, R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (ENGINEERING DEVELOPMENT), R&D-PROD/SERV IMPROVEMENT-ENG DEV, R&D- GENERAL SCIENCE/TECHNOLOGY: OTHER (COMMERCIALIZED), R&D-OTHER INCOME MAIN-COMERCLIZ

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $1,270,842 - Wednesday the 31st of July 2013
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    OTHER FUNCTIONS - TO ACQUIRE SERVICES FROM THE GLOBAL HIV/AIDS VACCINE ENTERPRISE (GHAVE)

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.